Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:CPH NASDAQ:CRON NYSEARCA:THCX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCPHCipher PharmaceuticalsC$16.30-0.2%C$17.42C$11.98▼C$20.56C$413.87M1.10463128,542 shs7,933 shsCRONCronos Group$2.69+1.3%$2.69$1.87▼$3.43$1.00B0.891.39 million shs372,687 shsTHCXAXS Cannabis ETF$16.60$16.60$14.90▼$25.40$141.07M1.7115,071 shsN/AThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCPHCipher Pharmaceuticals0.00%+0.80%-2.57%-1.15%+27.98%CRONCronos Group-2.21%+0.76%-3.28%+2.71%+42.47%THCXAXS Cannabis ETF0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCPHCipher PharmaceuticalsC$16.30-0.2%C$17.42C$11.98▼C$20.56C$413.87M1.10463128,542 shs7,933 shsCRONCronos Group$2.69+1.3%$2.69$1.87▼$3.43$1.00B0.891.39 million shs372,687 shsTHCXAXS Cannabis ETF$16.60$16.60$14.90▼$25.40$141.07M1.7115,071 shsN/AThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCPHCipher Pharmaceuticals0.00%+0.80%-2.57%-1.15%+27.98%CRONCronos Group-2.21%+0.76%-3.28%+2.71%+42.47%THCXAXS Cannabis ETF0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCPHCipher Pharmaceuticals 2.00HoldC$17.004.29% UpsideCRONCronos Group 2.20Hold$2.30-14.34% DownsideTHCXAXS Cannabis ETF 1.95Reduce$16.60N/ACurrent Analyst Ratings BreakdownLatest CPH, CRON, and THCX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/29/2026CRONCronos Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)5/12/2026CRONCronos Group TD SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/12/2026CPHCipher Pharmaceuticals Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetHoldC$17.00(Data available from 6/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCPHCipher PharmaceuticalsC$50.94M8.13C$4.62 per share3.53C$5.25 per share3.10CRONCronos Group$146.59M6.83$0.01 per share216.16$3.00 per share0.90THCXAXS Cannabis ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCPHCipher PharmaceuticalsC$11.41MC$1.1913.70N/AN/A60.82%25.69%7.90%N/ACRONCronos Group-$9.45M$0.01268.77N/AN/A-1.14%-1.26%-1.20%8/6/2026 (Estimated)THCXAXS Cannabis ETFN/AN/AN/AN/AN/AN/AN/AN/AN/ALatest CPH, CRON, and THCX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/11/2026Q1 2026CRONCronos Group$0.01$0.01N/A$0.04$42.20 million$58.97 million5/7/2026Q1 2026CPHCipher PharmaceuticalsN/AC$0.33N/AC$0.33N/AC$17.39 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCPHCipher PharmaceuticalsN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ATHCXAXS Cannabis ETF$0.724.34%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCPHCipher Pharmaceuticals0.321.252.67CRONCronos GroupN/A21.8720.73THCXAXS Cannabis ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCPHCipher Pharmaceuticals2.29%CRONCronos Group8.71%THCXAXS Cannabis ETFN/AInsider OwnershipCompanyInsider OwnershipCPHCipher Pharmaceuticals42.00%CRONCronos Group7.80%THCXAXS Cannabis ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCPHCipher Pharmaceuticals525.39 millionN/ANot OptionableCRONCronos Group450373.03 million343.94 millionOptionableTHCXAXS Cannabis ETFN/A8.50 millionN/ANot OptionableCPH, CRON, and THCX HeadlinesRecent News About These CompaniesCannabis Bioscience International Holdings Opens New Revenue Pathway with First VitaCookies Licensing AgreementJune 22 at 7:14 AM | newsfilecorp.comNAurora Cannabis: Weak Near-Term Outlook But Too Cheap To Ignore - BuyJune 12, 2026 | seekingalpha.comHerbal Dispatch Completes 452kg Multi Client Medical Cannabis Export Shipment To EuropeJune 9, 2026 | newsfilecorp.comNHerbal Dispatch Completes Export of 261kg of Medical Cannabis to EuropeMay 21, 2026 | newsfilecorp.comNHerbal Dispatch Completes Company Record 500kg Medical Cannabis Export Shipment to EuropeMay 19, 2026 | newsfilecorp.comNAurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis ScienceMay 14, 2026 | prnewswire.comVillage Farms: U.S. Cannabis Optionality (Rating Upgrade)May 13, 2026 | seekingalpha.comGreen Thumb Industries Will Benefit From Medical Cannabis ReschedulingMay 12, 2026 | seekingalpha.comInnovative Industrial Properties: Medical Cannabis Rescheduling Implies Bottoming Tenant Default Risks - Reiterate BuyMay 6, 2026 | seekingalpha.comHerbal Dispatch Launches Next-Generation E-Commerce Platform, Targeting High-Growth $245 Million Insured Medical Cannabis SegmentMay 5, 2026 | newsfilecorp.comNGlow Lifetech Expands Distribution with Two of Canada's Largest Cannabis Retailers, Launches New Product Innovation and Advances National Growth StrategyApril 30, 2026 | newsfilecorp.comNCannabis ETFs: Regulatory Momentum Returns FocusApril 30, 2026 | etftrends.comEHerbal Dispatch Advances U.S. Strategy amid Historic Cannabis Rescheduling ShiftApril 27, 2026 | newsfilecorp.comNAurora Cannabis: Why I Like This StockApril 24, 2026 | seekingalpha.comIM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash FlowMarch 31, 2026 | prnewswire.comCanopy Growth's Apollo Cannabis Clinics Named Best Medical Cannabis ClinicMarch 30, 2026 | businesswire.comHYTN Successfully Releases Cannabis Products in Germany and Accepts ReorderMarch 27, 2026 | globenewswire.comInnovative Industrial Properties: Deeply Undervalued As Cannabis Rescheduling Hits MilestoneMarch 27, 2026 | seekingalpha.comVillage Farms Shows Strong Q4 Performance But Cannabis Sector Remains Weak (Rating Downgrade)March 14, 2026 | seekingalpha.com3 Of The Best Cannabis Stocks In The Sector TodayMarch 9, 2026 | marijuanastocks.comMNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines5 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 20263 Stocks Rallying on Micron's Price Boost: Substance or Hype?By Dan Schmidt | May 28, 2026Micron’s $1 Trillion Memory Melt-UpBy Jeffrey Neal Johnson | May 27, 2026Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?By Jessica Mitacek | June 1, 2026If the Market Rally Stalls, This ETF Can Insulate PortfoliosBy Jessica Mitacek | May 28, 2026CPH, CRON, and THCX Company DescriptionsCipher Pharmaceuticals TSE:CPHC$16.30 -0.03 (-0.18%) As of 12:46 PM EasternCipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.Cronos Group NASDAQ:CRON$2.68 +0.04 (+1.32%) As of 01:07 PM Eastern This is a fair market value price provided by Massive. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.AXS Cannabis ETF NYSEARCA:THCX$16.60 0.00 (0.00%) As of 03/1/2024The Cannabis ETF (THCX) is an exchange-traded fund that is based on the AXS Cannabis index. The fund tracks an index of legal cannabis companies selected and weighted by market capitalization. The fund primarily holds North American companies but may also invest in other countries. THCX was launched on Jul 9, 2019 and is managed by AXS Investments. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Micron’s Sudden Plunge May Be an AI Buying Chance BitMine’s Ethereum Bet Is Only Part of the Story SpaceX Valuation Loses Altitude as AI Risks Mount Copa Holdings May Be the Airline Stock Built to Break Out Buy CrowdStrike Before the Stock Split? Here's the Case USA Today's Digital Revival Is Gaining Steam, But With Plenty of Risk Burlington Is Winning Over Shoppers But Investors Need Patience Investors Are Buying Into Sweetgreen Again—Should They? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
